(Q53916721)
Statements
Bioavailability of rifampicin in a separate formulation and fixed dose combination with isoniazid NIH: a case for a fixed dose combination (FDC) for the treatment of tuberculosis (English)
Nyazema NZ
Rabvukwa P
Gumbo J
Ndudzo P